Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis A Systematic Review and Meta-Analysis of 24,135 Patients /
Pain, fatigue, and physical activity are major determinants of life quality in rheumatoid arthritis (RA). Janus kinase (JAK) inhibitors have emerged as effective medications in RA and have been reported to exert direct analgesic effect in addition to reducing joint inflammation. This analysis aims t...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2022
|
| Sorozat: | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
23 No. 3 |
| Tárgyszavak: | |
| doi: | 10.3390/ijms23031246 |
| mtmt: | 32611722 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/23863 |